BBIO Submits NDA, 76% Achieve Calcium Targets vs 4% SOC, Fast‑Track, Launch 2027
BridgeBio Pharma, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $65.36
-4.8% in 3d after detection
Post-detection moves
1h
—
1d
+1.5%
3d
-4.8%
7d
+0.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS